BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 25188299)

  • 1. Analysis of gene expression profiles of soft tissue sarcoma using a combination of knowledge-based filtering with integration of multiple statistics.
    Takahashi A; Nakayama R; Ishibashi N; Doi A; Ichinohe R; Ikuyo Y; Takahashi T; Marui S; Yasuhara K; Nakamura T; Sugita S; Sakamoto H; Yoshida T; Hasegawa T; Takahashi H
    PLoS One; 2014; 9(9):e106801. PubMed ID: 25188299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer diagnosis marker extraction for soft tissue sarcomas based on gene expression profiling data by using projective adaptive resonance theory (PART) filtering method.
    Takahashi H; Nemoto T; Yoshida T; Honda H; Hasegawa T
    BMC Bioinformatics; 2006 Sep; 7():399. PubMed ID: 16948864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macrophage migration inhibitory factor and stearoyl-CoA desaturase 1: potential prognostic markers for soft tissue sarcomas based on bioinformatics analyses.
    Takahashi H; Nakayama R; Hayashi S; Nemoto T; Murase Y; Nomura K; Takahashi T; Kubo K; Marui S; Yasuhara K; Nakamura T; Sueo T; Takahashi A; Tsutsumiuchi K; Ohta T; Kawai A; Sugita S; Yamamoto S; Kobayashi T; Honda H; Yoshida T; Hasegawa T
    PLoS One; 2013; 8(10):e78250. PubMed ID: 24167613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T-cell infiltration and clonality correlate with programmed cell death protein 1 and programmed death-ligand 1 expression in patients with soft tissue sarcomas.
    Pollack SM; He Q; Yearley JH; Emerson R; Vignali M; Zhang Y; Redman MW; Baker KK; Cooper S; Donahue B; Loggers ET; Cranmer LD; Spraker MB; Seo YD; Pillarisetty VG; Ricciotti RW; Hoch BL; McClanahan TK; Murphy E; Blumenschein WM; Townson SM; Benzeno S; Riddell SR; Jones RL
    Cancer; 2017 Sep; 123(17):3291-3304. PubMed ID: 28463396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of heterogeneity among soft tissue sarcomas by gene expression profiles from different tumors.
    Skubitz KM; Pambuccian S; Manivel JC; Skubitz AP
    J Transl Med; 2008 May; 6():23. PubMed ID: 18460215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-152 down-regulation is associated with MET up-regulation in leiomyosarcoma and undifferentiated pleomorphic sarcoma.
    Pazzaglia L; Novello C; Conti A; Pollino S; Picci P; Benassi MS
    Cell Oncol (Dordr); 2017 Feb; 40(1):77-88. PubMed ID: 27900663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of subtype-specific group 1 leiomyosarcoma markers in a wide variety of sarcomas by gene expression analysis and immunohistochemistry.
    Mills AM; Beck AH; Montgomery KD; Zhu SX; Espinosa I; Lee CH; Subramanian S; Fletcher CD; van de Rijn M; West RB
    Am J Surg Pathol; 2011 Apr; 35(4):583-9. PubMed ID: 21412072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of p16(INK4a) is associated with reduced patient survival in soft tissue tumours, and indicates a senescence barrier.
    Knösel T; Altendorf-Hofmann A; Lindner L; Issels R; Hermeking H; Schuebbe G; Gibis S; Siemens H; Kampmann E; Kirchner T
    J Clin Pathol; 2014 Jul; 67(7):592-8. PubMed ID: 24747207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic and prognostic gene expression signatures in 177 soft tissue sarcomas: hypoxia-induced transcription profile signifies metastatic potential.
    Francis P; Namløs HM; Müller C; Edén P; Fernebro J; Berner JM; Bjerkehagen B; Akerman M; Bendahl PO; Isinger A; Rydholm A; Myklebost O; Nilbert M
    BMC Genomics; 2007 Mar; 8():73. PubMed ID: 17359542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of HER2/neu does not correlate with survival in soft tissue sarcoma.
    Sato T; Peiper M; Heinecke A; Zurakowski D; Eisenberger CF; Hosch S; Knoefel WT; Izbicki JR
    Onkologie; 2003 Jun; 26(3):268-71. PubMed ID: 12845212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin-like growth factor type 1 receptor expression correlates to good prognosis in highly malignant soft tissue sarcoma.
    Ahlén J; Wejde J; Brosjö O; von Rosen A; Weng WH; Girnita L; Larsson O; Larsson C
    Clin Cancer Res; 2005 Jan; 11(1):206-16. PubMed ID: 15671548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Machine learning analysis of gene expression data reveals novel diagnostic and prognostic biomarkers and identifies therapeutic targets for soft tissue sarcomas.
    van IJzendoorn DGP; Szuhai K; Briaire-de Bruijn IH; Kostine M; Kuijjer ML; Bovée JVMG
    PLoS Comput Biol; 2019 Feb; 15(2):e1006826. PubMed ID: 30785874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors in soft tissue sarcoma.
    Levine EA
    Semin Surg Oncol; 1999; 17(1):23-32. PubMed ID: 10402635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Genomic Grade Index predicts postoperative clinical outcome in patients with soft-tissue sarcoma.
    Bertucci F; De Nonneville A; Finetti P; Perrot D; Nilbert M; Italiano A; Le Cesne A; Skubitz KM; Blay JY; Birnbaum D
    Ann Oncol; 2018 Feb; 29(2):459-465. PubMed ID: 29069276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of Clinical and Molecular Factors Impacting Oncologic Outcomes in Undifferentiated Pleomorphic Sarcoma.
    Roland CL; May CD; Watson KL; Al Sannaa GA; Dineen SP; Feig R; Landers S; Ingram DR; Wang WL; Guadagnolo BA; Feig B; Hunt KK; Cormier JN; Lazar AJ; Torres KE
    Ann Surg Oncol; 2016 Jul; 23(7):2220-8. PubMed ID: 26847678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene expression profiling in leiomyosarcomas and undifferentiated pleomorphic sarcomas: SRC as a new diagnostic marker.
    Villacis RA; Silveira SM; Barros-Filho MC; Marchi FA; Domingues MA; Scapulatempo-Neto C; Aguiar S; Lopes A; Cunha IW; Rogatto SR
    PLoS One; 2014; 9(7):e102281. PubMed ID: 25028927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prognostic profile of hypoxia-induced genes for localised high-grade soft tissue sarcoma.
    Aggerholm-Pedersen N; Sørensen BS; Overgaard J; Toustrup K; Baerentzen S; Nielsen OS; Maretty-Kongstad K; Nordsmark M; Alsner J; Safwat A
    Br J Cancer; 2016 Oct; 115(9):1096-1104. PubMed ID: 27701385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathological and prognostic significance of chemokine receptor CXCR4 in patients with bone and soft tissue sarcoma: a meta-analysis.
    Li YJ; Dai YL; Zhang WB; Li SJ; Tu CQ
    Clin Exp Med; 2017 Feb; 17(1):59-69. PubMed ID: 26678086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. cDNA microarray-based translational research in soft tissue sarcoma.
    Lubieniecka JM; Nielsen TO
    J Surg Oncol; 2005 Dec; 92(4):267-71. PubMed ID: 16299802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrated molecular characterization of adult soft tissue sarcoma for therapeutic targets.
    Kim J; Kim JH; Kang HG; Park SY; Yu JY; Lee EY; Oh SE; Kim YH; Yun T; Park C; Cho SY; You HJ
    BMC Med Genet; 2018 Dec; 19(Suppl 1):216. PubMed ID: 30598078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.